Because of the unacceptably high rate of adverse patient events, including deaths, linked to the point-of-care (POC) use of glucose meters within hospitals, there is a recognized need for more accuracy and better performance standards for POC glucose testing in hospitals, particularly in intensive care settings.
StatStrip is designed specifically to measure and correct for clinical interferences that can be present in critically ill patients.
Proven safety and accuracy
Use of any other meter with critically ill patients is considered off label in the U.S. by the FDA and high complexity testing under CLIA
Use of any other glucose meter with critically ill patients is off label
StatStrip is FDA cleared and CLIA waived for use throughout all hospital and all professional healthcare settings including critical care. Use of any other glucose meter with critically ill patients is considered off-label in the U.S. by the FDA and high complexity testing under CLIA.
The personnel testing requirements for off-label use are very demanding and limit who can perform testing. In addition, a hospital must obtain patient consent to perform off-label testing.
The most extensively studied and proven glucose measurement technology
In addition to the studies submitted to the FDA, over 200 independent studies including 53 critical care studies—have found no clinically significant interferences for StatStrip. This is a statement that no other glucose meter manufacturer can make. Download a bibliography of publications here
For more information click here
Dimensions:
Weight: 0.49 lb (220 g)
Size: 5.8 in x 3.1 in x 1.18 in
(147 mm x 79 mm x 30 mm)
Data Storage:
Patient Tests: 1,000 tests
Patient Records: 3000 individuals*
* With optional ADT interface
QC Tests: 200 tests
Users: 8,000 Operators
Connectivity:
Meter Data Output: RJ-45 Ethernet Port via docking station, optional integrated Wi-Fi (802.11a/b/g/n)
Protocol: TCP/IP Ethernet 100M/1GBPS
Setup Instrument Manager Program: NovaNet™ Device Management Software
Interface Standard: POCT1-A2 Compliant
Connect to hospital ADT via NovaNet Device Management software. Connect to all LIS/EMR via all major middleware providers
Battery Information:
Type: 3.7V Li Polymer Rechargeable Battery
Features: Rechargeable/Replaceable
Life: 6-8 hours in use (approximately 40 tests w/barcode scans)/12-24 hours standby
Docking Station:
Desk or wall mount docking station with RJ-45 Ethernet jack providing network connection and battery charging. 3 LED indicator lights showing connection status, transmit/receive data, and charging status. Extra battery slot included for recharging and storage of spare battery.
Additional Features:
Designed for applications that do not need data interfacing and connectivity, Xpress2 Glucose retains all of the analytical performance features of StatStrip Glucose.
Dimensions:
Weight: 2.77 oz (78.5 g)
Size: 3.9 in x 2.4 in x 0.9 in
(98 mm x 61 mm x 22.9 mm)
Data Storage:
Patient & QC Tests: 400 tests total (FIFO)
Connectivity:
Data Transfer: Strip Port Connection to USB
Data Program: Nova Microsoft-Excel based data transfer software
Battery Information:
Type: 2 AAA batteries
Features: Replaceable
Life: Minimum 600 tests
Additional Features:
Tests:
Tests Measured: Glucose and Hematocrit
Test Reported: Glucose
Test Time: 6 Seconds
Test Strip Volume: 1.2 µL
Test Methodology: Electrochemistry
Sample Types & Operating Modes:
Whole Blood: Arterial, Venous, Capillary, Neonatal
Glucose Measurement Range: 10-600 mg/dL (0.6-33.3 mmol/L)
Interferences (Measured and Corrected for):
Hematocrit, Ascorbic Acid, Uric Acid, Acetaminophen (Paracetamol), Bilirubin, Maltose, Galactose, Oxygen
Operating Ranges:
Temperature: 15°C- 40°C (59°F-104°F)
Altitude: Up to 15,000 feet
Humidity: 10% to 90% relative humidity
Reagents and Strips:
Strips: Cases of 36 vials (1,800 strips); vials packaged 50 strips/vial
QC: Three levels (Low, Normal, High); sold separately
Linearity: Five levels available
Test Strip Stability:
24 months from date of manufacturing in USA
180-day open-vial stability
QC Stability:
24 months from date of manufacturing
90-day open-vial stability